<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Resources

Helping our clients find solutions to their challenges is our top priority. This library of case studies, journal articles and other publications are an excellent resource for your team.
Clear Filters

Publications

Filter by

Material Type
Topic
Therapy area

All Resources

Sorry no results please clear the filters and try again

simon-lee-zft-W1kVEhg-unsplash_1104_736
joel-filipe-uHJubAEZklE-unsplash_1104
bryan-garces-zwo-0E7l1ZI-unsplash_1104
mitchell-luo-xBxycG4ePTc-unsplash_1104
CytelTDT_HeroImage (1)
pawel-czerwinski-6YutWe6awpM-unsplash_1104
Stock_Okgo_Road_Long_Exposure_web
Northern lights_1104_736
conny-schneider-xuTJZ7uD7PI-unsplash_1104
jr-korpa-SFT9G3pAxLY-unsplash_1104
idmc-webainr-series
Grey triangle pattern
CytelTDT_HeroImage (1)
mitchell-luo-xW1TyrSA854-unsplash_1104
conny-schneider-xuTJZ7uD7PI-unsplash_1104
eduardo-filgueiras-HgcemeKoKqc-unsplash
system-2660914

ebook paper icon ebook

The Good Data Doctor on Data Submission and Data Integration

Read more
Green, dotted, textured pattern
richard-horvath-cPccYbPrF-A-unsplash_1104
adrien-olichon-PEcHvaxc8Vo-unsplash
derek-thomson-NqJYQ3m_rVA-unsplash_1104
White, grey and blue diamond pattern 2

webinar paper icon webinar

Comparative Effectiveness - methods and techniques for better decision making

Watch on Demand
conny-schneider-pREq0ns_p_E-unsplash

webinar paper icon webinar

Proposed platform using miniPDX to overcome some limitations

Read more
webinar-apac-series

webinar paper icon webinar

Can Co-Clinical Trials be a solution for me? Part 2

Read more
IMAGE_Cytel_Aug22_Carousel-Images_Bayesian_v3-2

webinar paper icon webinar

Can Co-Clinical Trials be a solution for me? Part 1

Read more
vishal-vasnani-QMhF0-q8oKg-unsplash

webinar paper icon webinar

Design considerations for early phase clinical trials of immuno-oncology drug
Read more
eduardo-filgueiras-HgcemeKoKqc-unsplash

webinar paper icon webinar

Novel Methods of Trial Design
Read more
jonas-jacobsson-0FRJ2SCuY4k-unsplash

white paper icon White Paper

Topics in Bayesian Statistical Methods
Read more
Cytel_35_Twitter

white paper icon White Paper

35 Years of Innovation: An Interview Series
Read more
silvio-kundt-Fixg8KipOg8-unsplash

webinar paper icon webinar

Functional Diagnosis for Patient Stratification in New Drug R&D
Read more
5be9862bbf934-royalty-free-thumbnail

webinar paper icon webinar

Functional Diagnosis for Patient Stratification in New Drug R&D

Read more
scott-webb-OxHPDs4WV8Y-unsplash

white paper icon White Paper

LiveSLR: The Urgent Need to Demonstrate Value in Real Time
Read more
scott-webb-aHhhdKUP77M-unsplash

webinar paper icon webinar

Future direction of interactive tool for health technology assessment: LiveBIM, LiveOS, LiveUtility, & LiveCEM
Read more
bryan-colosky-3ChXTytXDUI-unsplash

webinar paper icon webinar

HTA direction and implementation tools for the future of health care decisions (LiveSLR & LiveNMA)
Read more
unsplash_ricardo-gomez-angel-j5gCOKZdm6I

webinar paper icon webinar

US Drug Pricing Reform: Potential impact on Pharma HEOR evidence generation
Read more
absolutvision--XnURgeV0Xk-unsplash-1

articlesinterviews  icon Articles & Interviews

Tracking the Pandemic
Read more
nathan-duck-KnLj3o9A66E-unsplash

articlesinterviews  icon Articles & Interviews

Statistical Innovation Could Elevate Global Clinical Trials
Read more
ash-edmonds-gcINRBbUxl0-unsplash

articlesinterviews  icon Articles & Interviews

Cytel: modern trials could benefit from historical approach
Read more
gradienta-m_7p45JfXQo-unsplash_1104_736

articlesinterviews  icon Articles & Interviews

What’s the deal with Ivermectin and COVID?
Read more
alex-wong-l5Tzv1alcps-unsplash

articlesinterviews  icon Articles & Interviews

Closing the Biometrics Skills and Services Gap in Australia
Read more
parrish-freeman-0d-z8cJGIR4-unsplash

white paper icon White Paper

Identifying Choice Trial Designs Using Pareto
Read more
scott-webb-OxHPDs4WV8Y-unsplash

webinar paper icon webinar

Platform trials, Master protocols and the challenges in execution
Read more
anna-sullivan-_z9hFRHF6f4-unsplash

webinar paper icon webinar

Introduction to Design and Monitoring of Adaptive Clinical Trials
Read more
ricardo-gomez-angel-9AdeEdYB2yk-unsplash

webinar paper icon webinar

Network Meta-Interpolation, A Novel Approach to Adjust for Effect Modification in Network Meta-analysis Using Subgroup...
Read more
clark-van-der-beken-IQeBZm8F-M4-unsplash

webinar paper icon webinar

When and How to Adjust for Effect Modifiers in Population-Adjusted Indirect Treatment Comparisons? What Not to Do?
Read more
bryan-colosky-3ChXTytXDUI-unsplash

white paper icon White Paper

Monte Carlo Simulations for Patient Recruitment
Read more
scott-webb-aHhhdKUP77M-unsplash

ebook paper icon ebook

The Good Data Doctor on Data Submission and Data Integration
Read more
luca-bravo-xnqVGsbXgV4-unsplash_1

ebook paper icon ebook

Discover the Value of an Optimized Clinical Data Strategy
Read more
hector-j-rivas-1FxMET2U5dU-unsplash

webinar paper icon webinar

Embrace The Digital Era of Clinical Trials in China  - Challenges and Opportunities
Read more
alex-wong-l5Tzv1alcps-unsplash

Platform trials, Master protocols and the challenges in execution
Read more
ash-edmonds-gcINRBbUxl0-unsplash

webinar paper icon webinar

Introduction to Design and Monitoring of Adaptive Clinical Trials
Read more
scott-webb-mV9-1XjnM4Y-unsplash

webinar paper icon webinar

Design for results: statistical software to optimize your clinical development strategy
Read more
clark-van-der-beken-Tk0B3Dfkf_4-unsplash

webinar paper icon webinar

Effect Modifiers in Indirect Treatment Comparisons; Steps To Ensure the Unbiased Identification to Inform Decision Making
Read more
jason-leung-UMncYEfO9-U-unsplash

webinar paper icon webinar

Estimands, Estimators, and Estimates: Aligning target of estimation, method of estimation, and sensitivity analysis,...
Read more
clark-van-der-beken-IQeBZm8F-M4-unsplash

webinar paper icon webinar

Reinventing Trial Design in the Digital Era
Read more
scott-webb-mV9-1XjnM4Y-unsplash

webinar paper icon webinar

Adaptive Design in early phase Clinical Trials
Read more
ricardo-gomez-angel-9AdeEdYB2yk-unsplash

webinar paper icon webinar

Evolution of Estimand framework and use in Clinical Trials
Read more
Webinar Yuan Ji

webinar paper icon webinar

Bayesian Statistics with Applications in Clinical Trials in the New Era
Read more
enforesys-webinar

webinar paper icon webinar

Precision Recruitment Forecasting with Simulation-Based Technologies
Read more
Solara-podcast-image-northern-lights

podcast icon Podcast

Aligning Clinical Strategy with Regulatory and Market Objectives Through Modern Forecasting
Read more
maria-vojtovicova-7cfAzY0mj9w-unsplash

webinar paper icon webinar

Empowered Trial Selection with Weighting and Prioritization Tools
Read more
lightscape-LtnPejWDSAY-unsplash

case study icon Case Study

Strategic Clinical Trial Design Unlocks Innovative Funding Opportunity
Read more
nicolas-j-leclercq-va_nrBLonf8-unsplash

case study icon Case Study

Optimizing Interim Analyses to Conserve Resources and Speed Strong Therapies to Market
Read more
julien-moreau-688Fna1pwOQ-unsplash

webinar paper icon webinar

Head to Head Comparisons Using Real World Data – Study Design Considerations and an Update on the Pilot Investigation...
Read more
william-daigneault-7c8z4KEvgds-unsplash

webinar paper icon webinar

Designing Clinical Trials from a Program Perspective
Read more
julien-moreau-688Fna1pwOQ-unsplash

webinar paper icon webinar

Real-world Implementation of Drug Therapies Webinar Series
Read more
Abstract image of building

webinar paper icon webinar

Adaptive and Bayesian Designs for Dose-Finding
Read more
education1resources_page

white paper icon White Paper

Employing the Power of Bayesian Methods to Expedite Learning
Read more
education6resources_page

white paper icon White Paper

Overcoming Clinical Development Challenges in Oncology with Innovative, Adaptive Trial Design
Read more
education7resources_page

ebook paper icon ebook

Demystifying synthetic control arms
Read more
education4resources_page

white paper icon White Paper

Biometrics for your modern oncology trials
Read more
education8resources_page

white paper icon White Paper

Adaptive Trials at the Mainstream of Drug Development
Read more
education5resources_page

white paper icon White Paper

Use of Real-world evidence expands to transform drug development
Read more
education9resources_page

white paper icon White Paper

Re-imagining Clinical Trials Whitepaper
Read more
education3resources_page

white paper icon White Paper

Adaptive Trials for Clinical Trials - NEJM
Read more
education2resources_page

case study icon Case Study

Case study: Napo-Fulyzaq-Adaptive Two-stage-Seamless-design
Read more
Stock_abstract

webinar paper icon webinar

Group Sequential Designs and Sample Size Re-estimation - Modern Uses
Read more
paul-smith-Sz0kMDeDUc0-unsplash-1

webinar paper icon webinar

Estimands: Not Just a Statistical Issue
Read more
engin-akyurt-Qqeoz7YSNYg-unsplash

webinar paper icon webinar

Adaptive Multi-arm Multi-stage Clinical Trials
Read more
ricardo-gomez-angel-j5gCOKZdm6I-unsplash

webinar paper icon webinar

Head to Head Comparisons Using Real World Data - The Time for Causal inference is Now
Read more
joel-filipe-Wc8k-KryEPM-unsplash

webinar paper icon webinar

Harnessing the potential of wearables in clinical trials
Read more
Red colour bokeh abstract light background. Illustration

webinar paper icon webinar

Optimizing Market Access for Medical Devices
Read more
abstract

case study icon Case Study

Case Study: From Trial Design to CDISC Submission
Read more
education8resources_page

case study icon Case Study

Case Study: Improving Go/No-go Decision Making with Custom Software
Read more
education2resources_page

case study icon Case Study

Case Study: Dose-response modeling informs Phase 2 ulcerative colitis study design
Read more
education1resources_page

case study icon Case Study

Case Study Series III: Dose Finding & Dose Response Modeling in Pediatric Asthma
Read more
Solara-image-3

case study icon Case Study

Da Volterra leverages Solara to de-risk their clinical trial and optimize commercial strategy
Read more
iStock-1161463209-1

audiobook icon audiobook

Demystifying synthetic control arms (Audiobook)
Read more
resource-special-report

articlesinterviews  icon Articles & Interviews

Special Report on Clinical Trials: Delving into decentralization
Read more
joel-filipe-Wc8k-KryEPM-unsplash

white paper icon infographic

Is your Trial a Candidate for a Synthetic Control Arm
Read more
charles-forerunner-1727-unsplash

ebook paper icon ebook

Are You Harnessing the Power of Your Clinical Data?
Read more
pawel-czerwinski-_GVV5SViV2E-unsplash copy

ebook paper icon ebook

Innovative Data Science and Real-World Analytics Approaches in Practice
Read more
resource-reimagining-clinical-trial-infographic

white paper icon infographic

Reimagining Clinical Trial Design
Read more
jean-philippe-delberghe-75xPHEQBmvA-unsplash

white paper icon infographic

East Bayes - Enhanced Access to Innovative Bayesian Clinical Trial Designs
Read more
william-daigneault-7c8z4KEvgds-unsplash

articlesinterviews  icon Articles & Interviews

Adapt and Update: The Benefits of Bayesian
Read more
ricardo-gomez-angel-UD5drKd4H6w-unsplash

webinar paper icon webinar

Adaptive Dose-Finding Designs: Improving Drug Development Strategies
jason-leung-UMncYEfO9-U-unsplash

webinar paper icon webinar

Optimizing Drug Development with Model Informed Decision Making
Read more
engin-akyurt-Qqeoz7YSNYg-unsplash

webinar paper icon webinar

New Drug Development Paradigm
Read more
joel-filipe-Wc8k-KryEPM-unsplash

webinar paper icon webinar

Resolving Prior-Data Conflict
Read more
andrew-ridley-jR4Zf-riEjI-unsplash

webinar paper icon webinar

Adaptive Trials for Non-Statisticians
jj-ying-WmnsGyaFnCQ-unsplash

webinar paper icon webinar

Harness Patient Reported Outcomes
Read more
clay-banks-lkA6qT_aGds-unsplash

webinar paper icon webinar

Designing Event-based Studies: Reduce Sample Size and Increase Predictability
Read more
ricardo-gomez-angel-j5gCOKZdm6I-unsplash

webinar paper icon webinar

Key Design Considerations for Basket Trials and Umbrella Trials
Read more
jj-ying-7JX0-bfiuxQ-unsplash (1)

webinar paper icon webinar

Adaptive Umbrella Trial Using MAMS Module
dhruv-weaver-DtNOKuodKD4-unsplash

webinar paper icon webinar

Transparent Machine Learning
Read more
ricardo-gomez-angel-5YM26lUicfU-unsplash

webinar paper icon webinar

Phase 1 dose escalation trials with ESCALATE
Read more
jean-philippe-delberghe-75xPHEQBmvA-unsplash

webinar paper icon webinar

A Clinician’s Perspective on Cancer Drugs Development
paul-smith-Sz0kMDeDUc0-unsplash-1

webinar paper icon webinar

Phase 2 Dose-finding Studies with MCP and Modelling Techniques
Read more
luca-colapinto-I378DhssWqU-unsplash-1

webinar paper icon webinar

Conducting Sample Size Reassessment with Time-to-event Endpoints
Read more
alvaro-pinot-czDvRp5V2b0-unsplash

webinar paper icon webinar

Refocus your Enrollment to the Sub-population of Interest with ENRICH
Read more
gregoire-herve-bazin-thwEK6fkabw-unsplash

webinar paper icon webinar

Study Designs for Oncology and Rare Diseases
Read more
joakim-nadell-683417-unsplash (2)

webinar paper icon webinar

Innovative Drug Development at a Glance - The Concepts, The Vision, & The Factors to Consider
Read more
julien-moreau-688Fna1pwOQ-unsplash

webinar paper icon webinar

Estimands in Oncology Panel Discussion
Read more
ricardo-gomez-angel-UD5drKd4H6w-unsplash

webinar paper icon webinar

Bayesian Approaches to Address Clinical Development Challenges for COVID-19 Vaccine/Drugs/Devices
Read more
ricardo-gomez-angel-0rgv6FdK9hs-unsplash

webinar paper icon webinar

Synthetic and External Control Arms in Clinical Trials
Read more
joel-filipe-Wc8k-KryEPM-unsplash

webinar paper icon webinar

Practical Model-based Approaches for Phase I Oncology Trials
Read more
paul-smith-Sz0kMDeDUc0-unsplash-1

webinar paper icon webinar

Introduction to Population Enrichment Trial Designs
Read more
jean-philippe-delberghe-75xPHEQBmvA-unsplash

webinar paper icon webinar

Head to Head Comparisons Using Real World Data
Read more
bady-abbas-hxi_yRxODNc-unsplash

webinar paper icon webinar

Adaptive and Bayesian Designs for Dose-Finding
Read more
dhruv-weaver-DtNOKuodKD4-unsplash

webinar paper icon webinar

Designing Clinical Trials from a Program Perspective
Read more
ricardo-gomez-angel-5YM26lUicfU-unsplash

webinar paper icon webinar

StatXact for Small, Skewed, and Sparse Data Sets
Read more
jason-leung-UMncYEfO9-U-unsplash

webinar paper icon webinar

Head to Head Comparisons Using Real World Data
Read more
ricardo-gomez-angel-j5gCOKZdm6I-unsplash

webinar paper icon webinar

Case Study on the Value of Detailed Clinical Trial Simulations for Rare Diseases
Read more
joel-filipe-asL4k-U3I_s-unsplash (1)-1

webinar paper icon webinar

Key Design Considerations for Platform Trials
Read more
joakim-nadell-683417-unsplash (2)

webinar paper icon webinar

Re-imagining Clinical Trials: An Advanced Design Framework for the Era of Cloud-Computing
Read more
absolutvision--XnURgeV0Xk-unsplash

webinar paper icon webinar

Artificial Intelligence for Clinical Research - Prediction and Causal Inference
Read more
william-daigneault-7c8z4KEvgds-unsplash

webinar paper icon webinar

Clinical Trial Design and Decision Making in a Broader Context - Program & Portfolio Optimization
Read more
julien-moreau-688Fna1pwOQ-unsplash

webinar paper icon webinar

Head to head comparisons using Real world Data - Practical Applications
Read more
engin-akyurt-Qqeoz7YSNYg-unsplash

webinar paper icon webinar

The Long-term Industry Effects of COVID-19
Read more
ricardo-gomez-angel-0rgv6FdK9hs-unsplash

webinar paper icon webinar

Synthetic Control Mythbusters
Read more
jj-ying-7JX0-bfiuxQ-unsplash (1)

webinar paper icon webinar

Target Trial Emulation Using Real-World Data
Read more
jean-philippe-delberghe-75xPHEQBmvA-unsplash

webinar paper icon webinar

De-Risking the Unknown: Optimizing Statistical Design for Clinical Strategy
Read more
andrew-ridley-jR4Zf-riEjI-unsplash

webinar paper icon webinar

Innovations in Bayesian Clinical Trials Virtual Symposium
Read more
luca-colapinto-I378DhssWqU-unsplash-1

webinar paper icon webinar

Hi3+3: A Model-Assisted Dose-Finding Design Borrowing Historical Data
Read more
ricardo-gomez-angel-j5gCOKZdm6I-unsplash

case study icon Case Study

Strategic Clinical Trial Design Unlocks Innovative Funding
Read more
park-troopers-BeXgX5JS8KE-unsplash

ebook paper icon ebook

The Fundamentals of Real World Evidence in Oncology Drug Development
Read more
jason-leung-UMncYEfO9-U-unsplash

webinar paper icon webinar

Expanding Applications of Master Protocols
Read more
silvio-kundt-Fixg8KipOg8-unsplash

webinar paper icon webinar

Functional Diagnosis for Patient Stratification in New Drug R&D
Read more
Read more

Publications

Key Publications
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
PSE RELEVANT PUBLICATIONS

  • Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease (2022) pp. 13-21.
  • Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial (2022) pp. e42-e51
    Reis G, Dos Santos Moreira-Silva EA, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, de Souza Campos VH, Nogueira AMR, de Almeida APFG, Callegari ED, de Figueiredo Neto AD, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Glushchenko AV, Rayner CR, Lenze EJ, Reiersen AM, Guyatt GH, Mills EJ; TOGETHER investigators.
  • Optimal adaptive promising zone designs (2022) Mehta C, Bhingare A, Liu L, Senchaudhuri P.
  • Implementation of platform trials in the COVID-19 pandemic: A rapid review (2022)
    Vanderbeek AM, Bliss JM, Yin Z, Yap C.
  • Evaluating COVID-19 vaccines in the real world (2022) pp. 1205-1206.
    Mills EJ, Reis G.
  • Effect of Early Treatment with Ivermectin among Patients with Covid-19 (2022).
    Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, Campos VHS, Nogueira AMR, de Almeida APFG, Callegari ED, Neto ADF, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Rowland-Yeo K, Guyatt GH, Boulware DR, Rayner CR, Mills EJ; TOGETHER Investigators.
  • Emulating a target trial of the comparative effectiveness of clomiphene citrate and letrozole for ovulation induction (2022) pp. 793-805.
    Yland JJ, Chiu YH, Rinaudo P, Hsu J, Hernán MA, Hernández-Díaz S.
  • The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment (2022)
    Cox O, Sammon C, Simpson A, Wasiak R, Ramagopalan S, Thorlund K.
  • Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review (2022).
    Russell-Smith TA, Gurskyte L, Muresan B, Mamolo CM, Gezin A, Cappelleri JC, Heeg B.
  • Humanistic and Economic Burden of Conversion Therapy Among LGBTQ Youths in the United States (2022)
    Forsythe A, Pick C, Tremblay G, Malaviya S, Green A, Sandman K.
  • Fluvoxamine for the Early Treatment of COVID-19: A Meta-analysis of Randomized Clinical Trials (2022).
    Guo CM, Harari O, Chernecki C, Thorlund K, Forrest JI.
  • Robust group sequential designs for trials with survival endpoints and delayed response (2022) pp. 343-360.
    Ghosh P, Ristl R, König F, Posch M, Jennison C, Götte H, Schüler A, Mehta C.
  • Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data (2022).
    Tremblay G, Groff M, Iadeluca L, Daniele P, Wilner K, Wiltshire R, Bartolome L, Usari T, Cappelleri JC, Camidge DR.
  • Solutions to problems of nonexistence of parameter estimates and sparse data bias in Poisson regression (2022) pp. 253-266.
    Joshi A, Geroldinger A, Jiricka L, Senchaudhuri P, Corcoran C, Heinze G.
  • Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR) (2022) pp. 35-48.
    Musat MG, Kwon CS, Masters E, Sikirica S, Pijush DB, Forsythe A.
  • How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature (2022) pp. 67-74. 
    Park JJH, Detry MA, Murthy S, Guyatt G, Mills EJ.
  • Helicobacter pylori infection treatment in the United States: clinical consequences and costs of eradication treatment failure (2022) pp. 1-17.
    Shah S, Hubscher E, Pelletier C, Jacob R, Vinals L, Yadlapati R.
  • Corrigendum: Pre-conceptional Maternal Vitamin B12 Supplementation Improves Offspring Neurodevelopment at 2 Years of Age: PRIYA Trial (2022).
    D'souza N, Behere RV, Patni B, Deshpande M, Bhat D, Bhalerao A, Sonawane S, Shah R, Ladkat R, Yajnik P, Bandyopadhyay SK, Kumaran K, Fall C, Yajnik CS.
  • ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-Offs (2022).
    Sarri G, Bennett D, Debray T, Deruaz-Luyet A, Soriano Gabarró M, Largent JA, Li X, Liu W, Lund JL, Moga DC, Gokhale M, Rentsch CT, Wen X, Yanover C, Ye Y, Yun H, Zullo AR, Lin KJ.
  • Epidemiology and treatment of patients with Chronic rhinosinusitis with nasal polyps in Germany-A claims data study (2022).
    Starry A, Hardtstock F, Wilke T, Weihing J, Ultsch B, Wernitz M, Renninger M, Maywald U, Pfaar O.
  • Defining Incidence of Acute Compartment Syndrome in the Research Setting: A Proposed Method From the PACS Study pp. S26-S32.
    Leroux A, Frey KP, Crainiceanu CM, Obremskey WT, Stinner DJ, Bosse MJ, Karunakar MA, O'Toole RV, Carroll EA, Hak DJ, Hayda R, Alkhoury D, Schmidt AH; METRC.
  • Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data (2022).
    Ghiani M, Maywald U, Wilke T, Heeg B.
  • Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group (2022).
    Buhtoiarov IN, Mba NI, Santos CDL, McCarten KM, Metzger ML, Pei Q, Bush R, Baker K, Kelly KM, Cole PD.
  • Burden of Pertussis in Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England (2022) pp. 35-51.
    Bhavsar A, Aris E, Harrington L, Simeone JC, Ramond A, Lambrelli D, Papi A, Boulet LP, Meszaros K, Jamet N, Sergerie Y, Mukherjee P.
  • Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data (2022).
    Knapp RK, Hardtstock F, Wilke T, Maywald U, Deiters B, Schneider S, Mouchet J.
  • Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development (2022).
    Medical Outreach Subteam of the Drug Information Association Bayesian Scientific Working Group, Clark J, Muhlemann N, Natanegara F, Hartley A, Wenkert D, Wang F, Harrell FE Jr, Bray R.
  • Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial (2022).
    Reis G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, Cruz Milagres A, Ferreira TS, Quirino Dos Santos CV, de Figueiredo Neto AD, Diniz Callegari E, Monteiro Savassi LC, Campos Simplicio MI, Barra Ribeiro L, Oliveira R, Harari O, Bailey H, Forrest JI, Glushchenko A, Sprague S, McKay P, Rayner CR, Ruton H, Guyatt GH, Mills EJ.
  • Developing a Prediction Model for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Model Building Approaches (2022).
    Basmadjian RB, Kong S, Boyne DJ, Jarada TN, Xu Y, Cheung WY, Lupichuk S, Quan ML, Brenner DR.
  • Comparison of Mortality Risk With Different Surgeon and Hospital Operative Volumes Among Individuals Undergoing Pancreatectomy by Emulating Target Trials in US Medicare Beneficiaries (2022).
    Madenci AL, Wanis KN, Cooper Z, Subramanian SV, Haneuse S, Hofman A, Hernán M.
  • Assessment of the Cow's Milk-related Symptom Score (CoMiSS) as a diagnostic tool for cow's milk protein allergy: a prospective, multicentre study in China (MOSAIC study) (2022).
    Vandenplas Y, Zhao ZY, Mukherjee R, Dupont C, Eigenmann P, Kuitunen M, Ribes Koninckx C, Szajewska H, von Berg A, Bajerová K, Meyer R, Salvatore S, Shamir R, Järvi A, Heine RG; MOSAIC Study Investigator Group.
  • Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries (2022).
    Nachega JB, Sam-Agudu NA, Machekano RN, Rabie H, van der Zalm MM, Redfern A, Dramowski A, O'Connell N, Pipo MT, Tshilanda MB, Byamungu LN, Masekela R, Jeena PM, Pillay A, Gachuno OW, Kinuthia J, Ishoso DK, Amoako E, Agyare E, Agbeno EK, Martyn-Dickens C, Sylverken J, Enimil A, Jibril AM, Abdullahi AM, Amadi O, Umar UM, Sigwadhi LN, Hermans MP, Otokoye JO, Mbala-Kingebeni P, Muyembe-Tamfum JJ, Zumla A, Sewankambo NK, Aanyu HT, Musoke P, Suleman F, Adejumo P, Noormahomed EV, Deckelbaum RJ, Fowler MG, Tshilolo L, Smith G, Mills EJ, Umar LW, Siedner MJ, Kruger M, Rosenthal PJ, Mellors JW, Mofenson LM; African Forum for Research and Education in Health (AFREhealth) COVID-19 Research Collaboration on Children and Adolescents.
  • Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial (2022).
    Jones RL, Ravi V, Brohl AS, Chawla S, Ganjoo KN, Italiano A, Attia S, Burgess MA, Thornton K, Cranmer LD, Cheang MCU, Liu L, Robertson L, Adams B, Theuer C, Maki RG.
  • Twins in Guinea-Bissau have a 'thin-fat' body composition compared to singletons (2022) pp. 1-7.
    Wagh R, Bjerregaard-Andersen M, Bandyopadhyay S, Yajnik P, Prasad RB, Otiv S, Byberg S, Hennild DE, Gomes GM, Christensen K, Sodemann M, Jensen DM, Yajnik CS.
  • Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies (2022).
  • Ritchlin CT, Mease PJ, Boehncke WH, Tesser J, Schiopu E, Chakravarty SD, Kollmeier AP, Xu XL, Shawi M, Jiang Y, Sheng S, Wang Y, Xu S, Merola JF, McInnes IB, Deodhar A.
  • Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study (2021) pp. 2093-2100.
    Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, Reis BY, Balicer RD.
  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection (2021) pp. 2032-2040.
    Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, Dold C, Fuskova M, Gilbert SC, Hirsch I, Humphries HE, Jepson B, Kelly EJ, Plested E, Shoemaker K, Thomas KM, Vekemans J, Villafana TL, Lambe T, Pollard AJ, Voysey M; Oxford COVID Vaccine Trial Group.
  • Global incidence and prevalence of idiopathic pulmonary fibrosis (2021) pp. 197.
    Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, Patel H, Kreuter M.
  • Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years (2021) pp. 4381-4392
    Korn S, Bourdin A, Chupp G, Cosio BG, Arbetter D, Shah M, Gil EG.
  • Randomised trials at the level of the individual (2021) pp. e691-e700.
    Park JJH, Ford N, Xavier D, Ashorn P, Grais RF, Bhutta ZA, Goossens H, Thorlund K, Socias ME, Mills EJ.
  • How COVID-19 has fundamentally changed clinical research in global health (2021) pp. e711-e720.
    Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, Condo J, Decloedt EH, Nachega JB, Reis G, Mills EJ.
  • A comparison of confidence distribution approaches for rare event meta-analysis (2021) pp. 5276-5297.
    Zabriskie BN, Corcoran C, Senchaudhuri P.
  • The role and challenges of cluster randomised trials for global health (2021) pp. e701-e710.
    Dron L, Taljaard M, Cheung YB, Grais R, Ford N, Thorlund K, Jahan F, Nakimuli-Mpungu E, Xavier D, Bhutta ZA, Park JJH, Mills EJ.
  • A permutation-based approach for heterogeneous meta-analyses of rare events (2021) pp. 5587-5604.
    Zabriskie BN, Corcoran C, Senchaudhuri P.
  • The Ci3+3 design for dual-agent combination dose-finding clinical trials (2021) pp. 1-20.
    Yuan S, Zhou T, Lin Y, Ji Y.
  • Urgently seeking efficiency and sustainability of clinical trials in global health (2021) pp. e681-e690.
    Park JJH, Grais RF, Taljaard M, Nakimuli-Mpungu E, Jehan F, Nachega JB, Ford N, Xavier D, Kengne AP, Ashorn P, Socias ME, Bhutta ZA, Mills EJ.
  • Changes in Eating Behaviour during SARS-CoV-2 Pandemic among the Inhabitants of Five European Countries (2021) pp. 1624. 
    Górska P, Górna I, Miechowicz I, Przysławski J.
  • Practical Impact of Modern Dose-Finding Designs When Compared With the 3 + 3 Design: An Editorial (2021) pp. 1584-1587.
    Ji Y, Yuan S.
  • Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week (2021) pp. 1922-1933.
    Januzzi JL Jr, Canty JM, Das S, DeFilippi CR, Gintant GA, Gutstein DE, Jaffe A, Kaushik EP, Leptak C, Mehta C, Pina I, Povsic TJ, Rambaran C, Rhyne RF, Salas M, Shi VC, Udell JA, Unger EF, Zabka TS, Seltzer JH.
  • Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small-cell lung cancer (2021) pp. 1453-1456.
    Hsu GG, MacKay E, Scheuer N, Ramagopalan SV.
  • Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further (2021) pp. 558-560.
    Zariffa N, Haggstrom J, Rockhold F.
  • REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results (2021) pp. e61-e63.
    Olshansky B, Bhatt DL, Miller M, Steg PG, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Mehta C, Mukherjee R, Ballantyne CM, Chung MK; REDUCE-IT Investigators.
  • A Review of Current Approaches to Defining and Valuing Innovation in Health Technology Assessment (2021) pp. 1773-1783.
    Hofmann S, Branner J, Misra A, Lintener H.
  • Using supervised machine learning approach to predict treatment outcomes of vedolizumab in ulcerative colitis patients (2021) pp. 1-16.
    Chen J, Girard M, Wang S, Kisfalvi K, Lirio R.
  • Growth in Infants with Cow's Milk Protein Allergy Fed an Amino Acid-Based Formula (2021) pp. 392-402.
    Vandenplas Y, Dupont C, Eigenmann P, Heine RG, Høst A, Järvi A, Kuitunen M, Mukherjee R, Ribes-Koninckx C, Szajewska H, von Berg A, Zhao ZY; Mosaic Study Investigator Group.
  • Child mortality associated with maternal HIV status: a retrospective analysis in Rwanda, 2005-2015 (2021).
    Remera E, Chammartin F, Nsanzimana S, Forrest JI, Smith GE, Mugwaneza P, Malamba SS, Semakula M, Condo JU, Ford N, Riedel DJ, Nisingizwe MP, Binagwaho A, Mills EJ, Bucher H.
  • A simulation-based comparison of estimation methods for adaptive and classical group sequential clinical trials (2021).
    Nelson BS, Liu L, Mehta C.
  • Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants (2021) pp. 2420-2430.
    Scheible H, Dyroff M, Seithel-Keuth A, Harrison-Moench E, Mammasse N, Port A, Bachmann A, Dong J, van Lier JJ, Tracewell W, Mitchell D.
  • Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer (2021).
    Ramagopalan S, Gupta A, Arora P, Thorlund K, Ray J, Subbiah V.
  • What Does the Economic Burden of Acute Myeloid Leukemia Treatment Look Like for the Next Decade? An Analysis of Key Findings, Challenges and Recommendations (2021) pp. 245-255.
    Forsythe A, Sandman K.
  • Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC) (2021) pp. 3359-3368.
    Hubscher E, Sikirica S, Bell T, Brown A, Welch V, Russell-Smith A, D'Amico P.
  • Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trial (2021) pp. 1580-1587.
    Ferreira JP, Lamiral Z, Bakris G, Mehta C, White WB, Zannad F.
  • Pre-conceptional Maternal Vitamin B12 Supplementation Improves Offspring Neurodevelopment at 2 Years of Age: PRIYA Trial (2021).
    D'souza N, Behere RV, Patni B, Deshpande M, Bhat D, Bhalerao A, Sonawane S, Shah R, Ladkat R, Yajnik P, Bandyopadhyay SK, Kumaran K, Fall C, Yajnik CS.
  • Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention (2021).
    Matthews AA, Szummer K, Dahabreh IJ, Lindahl B, Erlinge D, Feychting M, Jernberg T, Berglund A, Hernán MA.
  • Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial (2021) pp. 187.
    Ferreira JP, Rossignol P, Bakris G, Mehta C, White WB, Zannad F.
  • Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study (2021).
    Giovannoni G, Singer BA, Issard D, Jack D, Vermersch P.
  • Predictive accuracy of prenatal ultrasound findings for lower urinary tract obstruction: A systematic review and Bayesian meta-analysis (2021) pp. 1039-1048.
    Keefe DT, Kim JK, Mackay E, Chua M, Van Mieghem T, Yadav P, Lolas M, Santos JD, Skreta M, Erdman L, Weaver J, Fermin AS, Tasian G, Lorenzo AJ, Rickard M.
  • Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8 (2021).
    Port A, Shaw JV, Klopp-Schulze L, Bytyqi A, Vetter C, Hussey E, Mammasse N, Ona V, Bachmann A, Strugala D, Reh C, Goteti K.
  • Maternal vitamin B(12), folate during pregnancy and neurocognitive outcomes in young adults of the Pune Maternal Nutrition Study (PMNS) prospective birth cohort: study protocol (2021).
    Behere RV, Deshpande G, Bandyopadhyay SK, Yajnik C.
  • Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial (2021) pp. 1006-1019.
    Ferreira JP, Sharma A, Mehta C, Bakris G, Rossignol P, White WB, Zannad F.
  • Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data (2021).
    Wilkinson S, Gupta A, Scheuer N, Mackay E, Arora P, Thorlund K, Wasiak R, Ray J, Ramagopalan S, Subbiah V.
  • Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome (2021) pp. 1612-1624.
    Rossello X, Ferreira JP, Caimari F, Lamiral Z, Sharma A, Mehta C, Bakris G, Cannon CP, White WB, Zannad F.
  • A Chatbot to Engage Parents of Preterm and Term Infants on Parental Stress, Parental Sleep, and Infant Feeding: Usability and Feasibility Study (2021).
    Wong J, Foussat AC, Ting S, Acerbi E, van Elburg RM, Mei Chien C.
  • Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II (2021) pp. 938-949.
    Reinisch W, Sandborn WJ, Danese S, Hébuterne X, Kłopocka M, Tarabar D, Vaňásek T, Greguš M, Hellstern PA, Kim JS, Sparrow MP, Gorelick KJ, Hoy M, Goetsch M, Bliss C, Gupta C, Cataldi F, Vermeire S.
  • Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design (2021) pp. 2575-2584.
    Walsh L, Reilly JF, Cornwall C, Gaich GA, Gipson DS, Heerspink HJL, Johnson L, Trachtman H, Tuttle KR, Farag YMK, Padmanabhan K, Pan-Zhou XR, Woodworth JR, Czerwiec FS.
  • The Critical Need for Pooled Data on Coronavirus Disease 2019 in African Children: An AFREhealth Call for Action Through Multicountry Research Collaboration (2021) pp. 1913-1919.
    Sam-Agudu NA, Rabie H, Pipo MT, Byamungu LN, Masekela R, van der Zalm MM, Redfern A, Dramowski A, Mukalay A, Gachuno OW, Mongweli N, Kinuthia J, Ishoso DK, Amoako E, Agyare E, Agbeno EK, Mohammed Jibril A, Abdullahi AM, Amadi O, Mohammed Umar U, Ayele BT, Machekano RN, Nyasulu PS, Hermans MP, Otshudiema JO, Bongo-Pasi Nswe C, Kayembe JN, Mbala-Kingebeni P, Muyembe-Tamfum JJ, Aanyu HT, Musoke P, Fowler MG, Sewankambo N, Suleman F, Adejumo P, Tsegaye A, Mteta A, Noormahomed EV, Deckelbaum RJ, Zumla A, Mavungu Landu DJ, Tshilolo L, Zigabe S, Goga A, Mills EJ, Umar LW, Kruger M, Mofenson LM, Nachega JB; Investigators in the AFREhealth COVID-19 Research Collaboration on Children and Adolescents.
  • Zariffa, N., Haggstrom, J. & Rockhold, F. Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further. Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00250-z
  • Harari O, Hsu G, Dron L, Park JJH, Mills EJ, Thorlund K. Utilizing Bayesian Predictive Power in Clinical Trial Design. Pharmaceutical Statistics. 2020; 1– 16. https://doi.org/10.1002/pst.2073
  • Forrest JI, Rayner CR, Park JJH, Mills EJ. Early Treatment of COVID-19 Disease: A Missed Opportunity. Infectious Diseases and Therapy. 2020; DOI: 10.1007/s40121-020-00349-8
  • Dillman A, Park JJH, Zannat NE, Lee Z, Dron L, Hsu G, Smith G, Khakabimamaghani S, Harari O, Thorlund K, Mills EJ. Reporting and Design of Randomized Clinical Trials for COVID-19: A Systematic Review. Contemporary Clinical Trials. 2021;101:106239.
  • Dillman A, Zorratti M, Park JJH, Hsu G, Dron L, Smith G, Harari O, Rayner CR, Zannat NE, Gupta A, Mackay E, Arora P, Lee Z, Mills EJ. The landscape of emerging randomized clinical trial evidence for COVID-19 disease stages: A systematic review of global trial registries. Infection and Drug Resistance. 2020. Accepted
  • Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 Craig R. Rayner, Louis Dron, Jay J. H. Park, Eric H. Decloedt, Mark F. Cotton, Vis Niranjan, Patrick F. Smith, Michael G. Dodds, Fran Brown, Gilmar Reis, David Wesche, Edward J. Mills
  • Lancet Global Health 4 series on “Series in Clinical Trials in Global Health” – Forthcoming: 
Park JJH, Grais R, Taljard M, Nakimuli-Mpungu E, Jehan F, Nachega J, Ford N, Xavier D, Kengne A, Ashorn P, Socias ME, Bhutta ZA, Mills EJ. Global health clinical trials: Urgently seeking efficiency and sustainability. Lancet Global Health, 2020. Accepted
 
Park JJH, Ford N, Xavier D, Ashorn P, Grais R, Bhutta ZA, Goossens H, Thorlund T, Socias ME, Mills EJ. Global health clinical trials: Randomised trials at the level of individual. Lancet Global Health, 2020. Accepted

 

Dron L, Taljard M, Cheung YB, Grais R, Ford N, Thorlund K, Jahan F, Nakimuli-Mpungu E, Xavier D, Bhutta ZA, Park JJH, Mills EJ. Global health clinical trials: Role and challenges of cluster randomized trials for global health. Lancet Global Health, 2020. Accepted
 
Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, Condo J, Decloedt EH, Nachega J, Reis G, Mills EJ. How COVID-19 fundamentally changed clinical research in global health. Lancet Global Health, 2020. Accepted

  • Chen, Xianwen MD; Ren, Cuiping MD; Li, Juan MD; Wang, Shangpei MD; Dron, Louis MSc; Harari, Ofir PhD; Whittington, Craig PhD The Efficacy and Safety of Piribedil Relative to Pramipexole for the Treatment of Early Parkinson Disease: A Systematic Literature Review and Network Meta-Analysis, Clinical Neuropharmacology: 7/8 2020 - Volume 43 - Issue 4 - p 100-106 doi: 10.1097/WNF.0000000000000400
  • Ghosh P, Liu L, Mehta CR. Adaptive Multiarm Multistage Clinical Trials. Statistics in Medicine, 2020; 39:1084-1102.
  • Ferreira JP, Mehta CR, Sharma A, Nissen SE, Rossignol P, Zannad F. Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial. BMC Medicine, 2020; 18:165.
  • Elharram M, Sharma A, White W, Bakris G, Rossignol P, Mehta CR, Ferreira JP, Zannad, F. Timing of Randomization after an Acute Coronary Syndrome in Patients with Type-2 Diabetes Mellitus. American Heart Journal, 2020 (in Press).
  • Ferreira JP, Rossignol P, Sharma, A, White WB, Mehta CR, Bakris G, Zannad, F. Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial. Clinical Research in Cardiology, 2020. Published on-line, DOI 10.1007/s00392-020-01729-3.
  • Ankolekar S., Mehta C., Mukherjee R., Hsiao S., Smith J., Haddad T. (2020) Monte Carlo Simulation for Trial Design Tool. In: Piantadosi S., Meinert C. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_251-1

 

  • Park, Jay JH, et al. "Association of early interventions with birth outcomes and child linear growth in low-income and middle-Income countries: Bayesian network meta-analyses of randomized clinical trials." JAMA network open 2.7 (2019): e197871-e197871.
  • Mehta, C. R., L. Liu, and C. Theuer. "An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)." Annals of Oncology 30.1 (2019): 103-108.
  • Hsiao, Samuel T., Lingyun Liu, and Cyrus R. Mehta. "Optimal promising zone designs." Biometrical Journal 61.5 (2019): 1175-1186.
  • Mehta, C. R., et al. “Exact Inference for Adaptive Group Sequential design,” in Liu, Ray, and Yi Tsong, eds. Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016. Vol. 218. Springer, 2019.
  • Park JJH, Siden E, Zoratti MJ, et al. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. BMC Trials 2019; 20(1): 572.
  • Siden EG, Park JJ, Zoratti MJ, et al. Reporting of master protocols towards a standardized approach: A systematic review. Contemporary Clinical Trials Communications 2019; 15: 100406.
  • Park JJ, Harari O, Dron L, Mills EJ, Thorlund K. Effects of biomarker diagnostic accuracy on biomarker-guided phase 2 trials. Contemporary Clinical Trials Communications 2019; 15: 100396.
  • Mills EJ, Nsanzimana S. Have clinical trials in HIV finally matured? Lancet HIV 2019; 6 (9): 561-563.
  • Zhang K, Arora P, Sati N, Béliveau A, Troke N, Veroniki AA, Rodrigues M, Rios P, Zarin W, Tricco AC. Characteristics and methods of incorporating randomized and nonrandomized evidence in network meta-analyses: a scoping review. Journal of Clinical Epidemiology 2019; 113:1-10.
  • Welch VA, Hossain A, Ghogomu E, Riddle A, Cousens S, Gaffey M, Arora P, Black R, Bundy D, Castro MC, Chen L. Deworming children for soil-transmitted helminths in low and middle-income countries: systematic review and individual participant data network meta-analysis. Journal of Development Effectiveness. 2019 Dec 7:1-9.
  • Dron L, Golchi S, Hsu G, Thorlund K. Minimizing control group allocation in randomized trials using dynamic borrowing of external control data - An application to second line therapy for non-small cell lung cancer. Contemporary Clinical Trials Communications 2019; 16: 100446.
  • Gupta, A., Slater, J. J., Boyne, D., Mitsakakis, N., Béliveau, A., Druzdzel, M. J., … Arora, P. (2019). Probabilistic Graphical Modeling for Estimating Risk of Coronary Artery Disease: Applications of a Flexible Machine-Learning Method. Medical Decision Making 2019; 39(8):1032-1044. 
  • Arora P, Boyne D, Slater JJ, Gupta A, Brenner DR, Druzdzel MJ. Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine. Value Health 2019; 22(4):439-445.
  • Jafar R, Labrosse M, Weaver JD, Retta SM, Wu C, Duraiswamy N. A Computational Study on Deformed Bioprosthetic Valve Geometries: Clinically Relevant Valve Performance Metrics. J Biomech Eng 2019.
  • Khakabimamaghani S, Kelkar YD, Grande BM, Morin RD, Ester M, Ziemek D. SUBSTRA: Supervised Bayesian Patient Stratification. Bioinformatics 2019; 35(18):3263-3272.
  • Gupta A, Arora P, Brenner D, Edmonson-Jones M, Parkhomenko E, Stevens W, Wagner S, Borrill J, Wu E. Application of a Machine Learning Model to Predict Survival Outcomes for Patients with Advanced Renal Cell Carcinoma (aRCC) Treated with Nivolumab. In41st Annual Meeting of the Society for Medical Decision Making 2019 Oct 23. 
  • Zhang K, Arora P, Sati N, Béliveau A, Troke N, Veroniki AA, Rodrigues M, Rios P, Zarin W, Tricco AC. Characteristics and methods of incorporating randomized and nonrandomized evidence in network meta-analyses: a scoping review. Journal of Clinical Epidemiology 2019; 113:1-10.
  • Arora P, Thorlund K, Brenner DR, Andrews JR. Comparative accuracy of typhoid diagnostic tools: A Bayesian latent-class network analysis. PLoS Neglected Tropical Diseases 2019; 8;13(5):e0007303.
  • Park JJH, Fang ML, Harari O, et al. Association of Early Interventions With Birth Outcomes and Child Linear Growth in Low-Income and Middle-Income Countries: Bayesian Network Meta-analyses of Randomized Clinical Trials. JAMA Netw Open 2019; 2(7): e197871.
  • Gupta A, Brenner DR, Arora P. PMU12 Scalable Decision-Analytic Modelling with Influence Diagrams. Value in Health. 2019 May 1;22:S251.
 
  • An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
    Annals of Oncology
    C R Mehta, L Liu, C Theuer
  • ADaM Intermediate Dataset: how to improve your analysis traceability
    PhUSE US Connect 2018, Paper SD16
    Tinazzi, A. Curto, T. and Aggarwal, A.
  • Confidence, credibility and prediction.
    METRON, 76(2), pp.251-268
    Aitkin, M. and Liu, C.
  • Liu L, Hsiao S, Mehta CR. Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-assessment. Statistics in Biosciences, 2018; 10(2):405-419.
  • Hwang Y-C, Morrow DA, ..., Mehta CR, ..., White WB. High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMNE trial. Diabetes, Obesity and Metabolism, 2018; 20(3):654-659.
  • Cavender M, White WB, ..., Cannon CP. Total Cardiovascular Events Analysis of the EXAMINE Trial in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome. Clinical Cardiology, 2018; vol 41, pages 1022-1027.
  • Green SJ, Mentz RJ, ..., Mehta CR, ...O'Connor CM. Reassessing the Role of Surrogate Endpoints in Drug Development for Heart Failure. Circulation, 2018; 138(10):1039-1053.
  • White WB, Jalil F, ..., Mehta CR, Zannad F. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Ischemic Heart Disease in the EXAMINE Trial. Journal of the American Heart Association, 2018; 7(20), e009114.
  • Menon V, Nichols SJ, ..., Mehta CR, ... Nissen SE. Fasiglifam-induced liver injury in patients with type-2 diabetes: results of a randomized controlled cardiovascular oucomes safety trial. Diabetes Care, 2018; 41:2608-2609.
  • Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert group.
    Pharmaceut. Statist., 2013, 12 255–259
    Phillips, A., Fletcher, C., Atkinson, G., Channon, E., Douiri, A., Jaki, T., Maca, J., Morgan, D., Roger, JH. and Terrill, P.
  • PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery.
    N Engl J Med., 2012; 366(5):409-20.
    Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, Terrill, P., Osterloh I and Loumaye E.
  • PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
    N Engl J Med., 2012; 366(5):421-32.
    Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, Nouri K, Selvaggi L, Sodowski K, Bestel E, Terrill, P., Osterloh I and Loumaye E.

COST-EFFECTIVENESS ANALYSES

COST-CONSEQUENCE MODELS

BUDGET IMPACT MODELS

4 ITC/NMA/STC/MAIC

QOL/UTILITY

RWE

SYSTEMATIC LITERATURE REVIEW AND BURDEN OF ILLNESS

EARLY ECONOMIC MODELS AND VALUE FRAMEWORKS

HEALTH ECONOMICS METHODS

ENDPOINT VALIDATION

HEALTH TECHNOLOGY ASSESSMENTS